BMJ trial: stem cells after heart attack lowered heart failure risk in weak hearts
Shares a news report of a BMJ clinical trial in which patients with weak heart function given stem cell therapy shortly after a heart attack had lower risk of heart failure and related hospital stays than with standard care. No numbers in the post.

